大型抑郁症患者首次诊断患者的初始精神药物处方和症状关联:单中心横截面研究
Yugo Ishihara1, Norio Sugawara1, Yasushi Kawamata1
1Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Neuropsychopharmacology reports
|November 21, 2024
概括
许多患有主要抑郁症 (MDD) 的首次诊断患者没有接受精神药物治疗. 处方与特定症状相关,这表明MDD患者的个性化治疗方法.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 有限的数据存在于新诊断的大型抑郁症 (MDD) 患者的精神药物处方.
- 了解最初的处方模式对于优化治疗策略至关重要.
研究的目的:
- 为了调查日本首次访问MDD患者的精神药物处方模式.
- 探索处方精神药和患者症状之间的关联.
主要方法:
- 对376名首次访问MDD患者的横截面分析.
- 使用抑郁症症状快速清单日本版本 (QIDS-J) 进行症状评估.
- 评估人格特征 (TIPI-J) 和精神病症状 (PS-J).
主要成果:
- 40.2%的患者至少服用了一种精神药物.
- 抗抑郁药被处方给了31.4%的人,而二类药物给了18.1%的人.
- 抗抑郁药的处方与特定的QIDS-J领域 (注意力/决策) 有关,与自我感知有负相关性.
结论:
- 超过一半的首次访问MDD患者没有接受精神药物治疗.
- 处方决定似乎受特定症状和个性特征的影响.
- 需要进一步的纵向研究来阐明这些关联.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
309
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
309
Antidepressant Drugs: Overview
360
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
360
Depressive Disorders: MDD and Dysthymia
61
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
61
Psychosis and Antipsychotic Drugs: Overview
178
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
178
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39


